Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A phase II study of low dose melphalan with thiotepa and fludarabine as preparative regimen for alternative donor transplantation.
Journal: Leukemia & lymphoma
Published: August 07, 2026
Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal: Journal for immunotherapy of cancer
Published: June 10, 2026
Stem cell transplant and graft versus host disease: designing and implementing a steroid-induced hyperglycemia tool kit.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 29, 2025
Chemotherapy and the somatic mutation burden of sperm.
Journal: JCI insight
Published: November 07, 2024
Philadelphia chromosome-positive T-cell acute lymphoblastic leukemia: a case report.
Journal: The Journal of international medical research
Published: February 29, 2024
Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens.
Journal: Frontiers in oncology
Published: March 14, 2023
Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: December 19, 2021
A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors.
Journal: Transplantation and cellular therapy
Published: October 25, 2021
Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 17, 2021
Last Updated: 09/26/2026